Refresh

Concord Biotech Ltd. - Research Center

543960 CONCORDBIO Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23
Income

Operating income

1,016.94 853.17
Expenses

Material consumed

241.61 193.27

Manufacturing expenses

104.97 97.65

Personnel expenses

123.05 110.28

Selling expenses

- -

Adminstrative expenses

115.76 108.68

Expenses capitalised

- -

Cost of sales

585.38 509.88

Operating profit

431.56 343.29

Other recurring income

33.78 35.31

Adjusted PBDIT

465.34 378.60

Financial expenses

2.55 4.51

Depreciation

53.59 54.03

Other write offs

- -

Adjusted PBT

409.19 320.05

Tax charges

104.46 81.93

Adjusted PAT

304.73 238.13

Non recurring items

-0.01 0.26

Other non cash adjustments

- -

Reported net profit

304.72 238.38

Earnigs before appropriation

1,475.05 1,223.89

Equity dividend

71.45 53.56

Preference dividend

- -

Dividend tax

- -

Retained earnings

1,403.60 1,170.33
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com